ARBUTUS BIOPHARMA CORP

ABUS · NASDAQ

Updated at 2026-11-16 20:57:40

$4.07-0.48%
Today's High
$4.18
Today’s Low
$4.00
ARBUTUS BIOPHARMA CORP (ABUS) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$4.04
Previous Close
$4.09
Volume
3.31M
Market Cap
$626.96M
P/E Ratio
4.09X
EPS
$0.78

Previous Day Range

$3.92$4.13

52-Week Range

$3.50$5.45

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
701 VETERANS CIRCLE, WARMINSTER, PA, UNITED STATES, 18974
Country
US
Listing Date
2010-11-13
Fiscal Year End
December
Shares Outstanding
198.11M
CIK
0001447028

Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States. The company is headquartered in Warminster, Pennsylvania.

Financial Metrics

Revenue

2026-09-30

$299K

2026-06-30

$1.01M

2026-03-31

$179.12M

2025-12-31

$1.05M

Operating Expenses

2026-09-30

$10.79M

2026-06-30

$6.97M

2026-03-31

$9.99M

2025-12-31

$8.68M

Net Income

2026-09-30

$59.11M

2026-06-30

-$5.14M

2026-03-31

$169.69M

2025-12-31

-$3.75M

Net Profit Margin

2026-09-30

19.77K%

2026-06-30

-507.19%

2026-03-31

94.73%

2025-12-31

-357.37%

Earnings Per Share

2026-09-30

$0.42

2026-06-30

$-0.03

2026-03-31

$1.19

2025-12-31

$-0.01

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

$59.13M

2026-06-30

-$5.11M

2026-03-31

$169.72M

2025-12-31

-$3.72M

Effective Tax Rate

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.